Biocryst Pharmaceuticals BCRX Balance Sheet (2010-2026)

NASDAQ BCRX
$8.27 -0.20 (-2.36%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Biocryst Pharmaceuticals Quarterly Balance Sheet

Periods 65 quarters
Latest Jun 2026

Biocryst Pharmaceuticals reported total assets of $557.85M and total liabilities of $1012.14M for the quarter ended Jun 2026, up 22.0% year over year. This balance sheet covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
199.60M504.39M395.50M272.57M246.90M304.77M155.14M146.22M150.91M110.64M84.33M78.41M96.84M104.71M105.19M88.03M84.08M89.74M171.59M154.97M
Short-term InvestmentsInvestments (Current)
3.21M47.96M144.91M179.96M119.54M243.02M264.45M246.69M278.34M252.22M193.62M233.17M216.14M189.90M172.00M128.79M185.01M66.81M197.60M
Cash & Current Investments
199.60M507.60M443.47M417.48M426.86M424.31M398.16M410.67M397.59M388.99M336.55M272.03M330.01M320.85M295.09M260.04M212.87M274.75M238.40M352.57M
Receivables - NetNet Receivables
26.21M27.38M36.41M41.49M42.61M41.51M48.64M57.67M53.65M54.15M60.59M68.76M72.46M76.28M93.39M91.18M91.33M106.82M109.27M110.76M
Receivables - OtherOther Receivables
Receivables
26.21M27.38M36.41M41.49M42.61M41.51M48.64M57.67M53.65M54.15M60.59M68.76M72.46M76.28M93.39M91.18M91.33M106.82M109.27M110.76M
Work In Process
Inventory
13.66M15.79M16.14M23.38M27.02M27.53M27.47M27.03M29.63M28.68M29.78M4.45M7.56M8.09M6.87M5.04M5.23M5.40M5.99M6.06M
Prepaid Assets
8.97M9.99M12.33M11.05M11.07M12.59M15.16M14.11M20.02M19.54M18.38M16.43M16.28M13.75M14.33M12.54M16.50M17.18M19.11M14.82M
Current Assets
252.74M566.14M511.71M494.85M509.00M516.50M490.88M511.06M502.47M495.97M447.10M363.46M427.12M421.97M409.98M398.46M355.68M404.35M373.62M484.68M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
7.83M8.71M8.80M8.70M8.46M8.62M8.38M8.44M9.00M7.91M7.83M7.66M7.42M7.78M7.59M8.46M8.40M8.78M9.37M9.06M
Long-Term Investments
6.83M34.33M18.08M3.43M3.44M64.32M19.43M20.32M20.55M10.10M39.67M61.16M20.57M
Other Non-Current Assets
5.19M6.47M7.21M6.98M6.80M6.81M7.05M6.95M11.46M0.08M12.96M12.46M15.65M5.16M4.85M3.59M4.39M5.67M19.70M19.56M
Non-Current Assets
13.02M22.02M16.01M15.69M49.59M33.50M18.85M18.83M20.46M20.99M20.79M108.96M64.13M68.45M70.07M58.73M90.74M109.81M91.43M73.17M
Assets
265.76M588.15M527.72M510.54M558.59M550.00M509.74M529.88M522.92M516.96M467.89M472.42M491.25M490.42M480.05M457.19M446.42M514.16M465.05M557.85M
Liabilities
Current Liabilities
Accounts Payables
19.69M27.81M13.88M12.02M8.62M14.36M6.25M13.89M10.57M20.89M11.91M7.79M13.48M11.64M10.05M8.59M5.57M15.83M10.96M11.46M
Notes Payables
30.00M
Payables
49.69M27.81M13.88M12.02M8.62M14.36M6.25M13.89M10.57M20.89M11.91M7.79M13.48M11.64M10.05M8.59M5.57M15.83M10.96M11.46M
Accumulated Expenses
56.31M72.67M63.58M79.71M69.27M87.56M75.21M75.30M77.39M102.88M79.25M89.60M104.20M113.29M92.64M107.11M118.78M126.41M119.40M121.89M
Other Accumulated Expenses
25.55M3.68M
Short term Debt
23.57M26.02M28.97M33.00M32.68M34.30M35.74M37.69M38.45M40.32M43.81M
Current Leases
1.45M0.85M1.59M1.64M1.68M1.84M1.83M1.79M1.62M1.44M1.31M1.24M1.09M
Current Taxes
2.62M
Current Deferred Revenue
0.60M1.42M1.47M1.52M1.55M1.22M1.20M1.78M0.52M5.41M12.32M
Total Current Liabilities
133.61M103.72M81.02M95.39M81.64M105.51M85.16M93.50M90.76M149.99M119.92M129.06M153.57M160.38M139.85M177.16M190.24M196.07M195.39M208.85M
Non-Current Liabilities
Capital Leases
5.04M1.78M2.85M2.51M2.12M2.08M2.12M2.31M2.04M1.74M1.44M1.17M0.85M
Non-Current Debt
132.05M136.08M140.24M144.52M223.87M231.62M232.52M293.18M298.00M303.23M308.48M313.82M314.33M314.87M315.41M242.79M194.37M395.20M395.40M
Non-Current Deffered Revenue
8.83M13.46M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
24.16M26.86M
Operating Leases
5.96M6.46M6.20M5.97M4.03M5.93M5.80M9.97M8.39M8.60M8.36M8.06M7.92M7.78M8.49M8.43M8.57M11.12M10.60M
Other Non-Current Liabilities
Total Non-Current Liabilities
Total Liabilities
412.81M695.14M691.93M723.77M801.25M844.60M838.02M918.60M933.91M972.49M944.06M948.02M959.82M966.35M931.97M878.78M834.31M633.31M1,018.89M1,012.14M
Shareholder's Equity
Total Debt
162.05M136.08M140.24M144.52M223.87M231.62M232.52M293.18M298.00M326.80M334.51M342.80M347.33M347.55M349.72M278.54M232.05M38.45M435.51M439.21M
Common Equity
-147.04M-106.99M-164.22M-213.23M-242.66M-294.60M-328.29M-388.71M-410.99M-455.53M-476.17M-475.61M-468.56M-475.93M-451.93M-421.59M-387.89M-119.15M-553.84M-454.29M
Liabilities and Shareholders Equity
265.76M588.15M527.72M510.54M558.59M550.00M509.74M529.88M522.92M516.96M467.89M472.42M491.25M490.42M480.05M457.19M446.42M514.16M465.05M557.85M
Retained Earnings
-1189.72M-1207.50M-1281.70M-1340.56M-1383.08M-1454.62M-1507.95M-1583.28M-1619.43M-1681.16M-1716.54M-1729.21M-1743.24M-1770.04M-1770.01M-1764.92M-1752.02M-1506.18M-2227.99M-2149.60M

Biocryst Pharmaceuticals Balance Sheet API

Pull Biocryst Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BCRX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY